학술논문
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
Document Type
Article
Author
Russell, R.J.; Chachi, L.; Siddiqui, S.; Brightling, C.E.; FitzGerald, J.M.; Backer, V.; Olivenstein, R.; Titlestad, I.L.; Ulrik, C.S.; Harrison, T.; Singh, D.; Chaudhuri, R.; Leaker, B.; McGarvey, L.; Wang, M.; Braddock, M.; Nordenmark, L.H.; Cohen, D.; Colice, G.; Parikh, H.; Laviolette, M.; Skjold, T.; Nielsen, L.C.; Howarth, P.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, July 2018, 6(7):499-510)
Subject
Language
English
ISSN
22132619
22132600
22132600